Free tool
Stocks listed on XETRA
We cover 39 companies listed on XETRA. The median market value in the group is $2.55B. Across the group, the median move over the past trading day is +0.92%. 55% of the 38 with a 200-day average trade above it. Price change over the past year runs from −31.7% to +62.2% across the middle 80 percent of the group, with a median of +0.7%.
Other lists in this group
Table
39 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| 88Q.DE | 4basebio PLC | $96.59M | Micro cap | −45.69% |
| 7V0.DE | Novogenia AG | $89.54M | Micro cap | −25.00% |
| HIGH.DE | Cantourage Group SE | $81.55M | Micro cap | +51.90% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| V3V.DE | FamiCord AG | $58.74M | Micro cap | −61.35% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| BXT.DE | BioNxt Solutions Inc. | $34.26M | Micro cap | −65.52% |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| AAQ1.DE | aap Implantate AG | $25.22M | Micro cap | −15.12% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | $22.49M | Micro cap | −22.03% |
| B8FK.DE | Biofrontera AG | $17.36M | Micro cap | −3.07% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| SBX.DE | SynBiotic SE | $6.15M | Micro cap | −76.63% |
| 27N0.DE | Cannovum Cannabis AG | $1.71M | Micro cap | +22.47% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| PTP.DE | Pentixapharm Holding AG | $1.06M | Micro cap | +5.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.